A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation.

We present a schizophrenic patient who experienced neuroleptic malignant syndrome with risperidone treatment due to variants of the CYP2D6 gene with reduced function. Clinicians need to be aware of this potential complication.